Optimising the discovery, development and clinical translation of safe and effective antigen specific tolerance inducing therapies to treat autoimmune disorders
With the race well and truly on to be first to market with novel antigen-specific immune tolerance therapies, the Antigen-Specific Immune Tolerance Europe 2018 will be dedicated to determining novel antigen identification, validation of preclinical models and ultimately the effective clinical translation of this research clinical setting.
Hear from some of our expert speakers why they are getting involved with this summit:
“To present our platform and its applications in the autoimmunity space, and to network with colleagues with interest in the same space”
Pieter Rottiers, ActoBio Therapeutics
“To network with peers in this rapidly developing field and discuss the latest findings and developments with them”
Poul Sørensen, Allero Therapeutics
“I look forward to translational insights from leaders in the field of antigen-specific immunotherapy”
Robert (Bob) Anderson, ImmusanT
View the complete onsite agenda, speaker faculty, networking opportunities, workshops and pricing here.